Late-stage trials show efficacy of Moderna's RSV vaccine in older adults

was 83.7 percent effective at preventing at least two symptoms, such as cough and fever, in adults 60 and older.

“RSV significantly affects the health of older and high-risk adults, particularly those with comorbidities,” Abdullah Baqui, a principal investigator for the study sites in Bangladesh and professor at Johns Hopkins Bloomberg School of Public Health, said . “This trial will help to understand the role of severe acute respiratory infections in older adult populations and inform the future implementation of vaccines in adults in lower-resource areas.”The study was conducted in roughly 37,000 participants age 60 and older and the data analysis was performed after 64 of the participants contracted the virus.

“Today’s results represent an important step forward in preventing lower respiratory disease due to RSV in adults 60 years of age and older. These data are encouraging, and represent the second demonstration of positive phase 3 trial results from our mRNA infectious disease vaccine platform after, Spikevax, our COVID-19 vaccine.

Only against cough and fever. Nyquil Cold and Flu is almost 100% effective against these two symptoms. Lol. What an incredibly misleading title.

Please do keep recommending a dangerous gene-modifying vaccine for a 'sometimes deadly' virus

Keyword 'sometimes'.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Moderna says RSV vaccine is 84% effective at preventing disease in older adultsRSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC. Sure They said the same thing about the Covid vaccine, before it wasn't. Remember? Where have we heard this before?
Source: CNBC - 🏆 12. / 72 Read more »

Moderna’s RSV Shot Prevents Most Cases in Older PeopleModerna Inc.’s vaccine against RSV was highly effective in preventing the lung disease in older people, paving the way for the company to seek its first...
Source: dallasnews - 🏆 18. / 71 Read more »

Moderna says its RSV vaccine for older adults is 84% effective at preventing serious illnessModerna announced Tuesday its RSV vaccine for older adults was about 84% effective at preventing severe disease and the company plans to ask the FDA for approval in 2023. Lol and they'll line up🤣 They seem trustworthy. 🤡
Source: ABC - 🏆 471. / 51 Read more »